Our research involves experiments with RNA Biology, RNA modifications/editing, mRNA-based therapeutics, lipid nanoparticle (LNP) and alternative delivery systems, targeted delivery, cancer immunology, auto immune disease, primary human cancer cells, cancer and stem cell transplantation models, mouse genetics, molecular biology, biochemistry and cell biology, chemical biology, immunology, functional genomics, CARIPSR screening, signal transduction, single-cell sequencing, spatial sequencing, metabolism, drug development, structural biology, and large-scale data analysis and computational biology. As a successful candidate, you will: Engage in a variety of advanced techniques, including but not limited to mRNA-based technologies, LNP development, targeted delivery, Flow cytometry, mass spectrometry/quantitative phospho-profiling, CyTOF, mouse genetics models, xenograft assays, retroviral gene delivery, chemical biology, drug development, whole exome sequencing and RNA-seq-analysis of clonal evolution of cancer, dot blots, RNA modification-seq, ChIP-seq, RIP-seq, PAR-CLIP-seq, single-cell sequencing, spatial sequencing, metabolism profiling, and pre-clinical drug testing in xenotransplantation models, etc.